Physician Reminders Fail to Increase ACE/ARB Use

Share this content:

Treatment reminders fail to increase the rate at which primary care physicians (PCPs) prescribe ACE inhibitors or angiotensin receptor blockers (ARBs) for elderly patients with chronic kidney disease (CKD), according to an online report in the Clinical Journal of the American Society of Nephrology.

In a study of 5,444 CKD patients older than 65 years and who had diabetes or proteinuria, ACE inhibitors or ARBs were prescribed for 77.1% of those whose PCPs received a standard laboratory prompt with kidney test results and for 76.9% of those whose PCPs received an enhanced prompt that recommended prescribing one of these agents, a nonsignificant difference.

Braden Manns, MD, and co-investigators found that for the subset of patients with an estimated glomerular filtration rate of less than 30 mL/min/1.73 m2, ACE inhibitor/ARB use was higher in the enhanced-prompt group.
You must be a registered member of Renal and Urology News to post a comment.